Drug observable

Code	`373064003`
Semantic tag	observable entity
Module	international
Definition	primitive
Effective time	20020731

574100023710711-Beta-hydroxyaetiocholanolone/creatinine mass concentration ratio in urine observable entity

586100023710111-Beta-hydroxyandrosterone/creatinine mass concentration ratio in urine observable entity

231100023710117-Alpha hydroxypregnanolone/creatinine molar concentration ratio in urine observable entity

67100023710717-Alpha-hydroxypregnanolone/creatinine mass concentration ratio in urine observable entity

52310002371055-Alpha tetrahydrocortisol/5-beta tetrahydrocortisol molar concentration ratio in urine observable entity

61010002371016-Methylmercaptopurine/6-thioguanine molar concentration ratio in red blood cells observable entity

491000237109APC (activated protein C) with factor V deficient plasma percent in plasma observable entity

57751000237106APCR (activated protein C resistance) presence in plasma observable entity

58751000237107APTT (activated partial thrombin time) by PNP (platelet neutralisation procedure) correction observable entity

30941000237108Adrenaline/creatinine molar concentration ratio in urine observable entity

811000237100Aetiocholanolone/creatinine mass concentration ratio in urine observable entity

3311000237106Aldosterone/renin molar concentration ratio in plasma observable entity

53071000237107Ambulant renin enzyme activity in plasma observable entity

2263131000000106Amfetamine in oral fluid qualitative result observable entity

2304121000000100Amfetamine in urine qualitative result observable entity

250802004Anaesthetic agent concentration observable entity

2161000237101Androstenedione/testosterone molar concentration ratio in plasma observable entity

1601000237102Androsterone/creatinine mass concentration ratio in urine observable entity

56211000237102Antithrombin III percent activity in plasma observable entity

4761000237109Bence Jones protein/creatinine mass concentration ratio in urine observable entity

2263141000000102Benzodiazepine in oral fluid qualitative result observable entity

2283521000000100Benzodiazepine in urine qualitative result observable entity

2263231000000103Benzoylecgonine in oral fluid qualitative result observable entity

1581000237109Betaine/creatinine molar concentration ratio in urine observable entity

51731000237109CMV (Cytomegalovirus) total antibody in serum qualitative result observable entity

60121000237108CMV (cytomegalovirus) IgG antibody in CSF qualitative result observable entity

64681000237105CMV (cytomegalovirus) IgG antibody in serum qualitative result observable entity

61121000237101CMV (cytomegalovirus) IgM antibody in CSF qualitative result observable entity

62681000237103CMV (cytomegalovirus) IgM antibody in serum qualitative result observable entity

2304041000000106Cannabinoid receptor agonist in urine qualitative result observable entity

2263251000000105Cocaine in oral fluid qualitative result observable entity

2304111000000106Cocaine metabolite in urine qualitative result observable entity

181000237102Collagen/creatinine molar concentration ratio in urine observable entity

26941000237108Coproporphyrin III/coproporphyrin I molar ratio in faeces observable entity

3791000237103Dehydroepiandrostenedione/creatinine mass concentration ratio in urine observable entity

371892002Delivered radiation dose observable entity

1331000237104Delta-aminolaevulinic/creatinine molar concentration ratio in urine observable entity

28871000237109Dopamine/creatinine molar concentration ratio in urine observable entity

446996006Dosage of radiation exposure observable entity

1376040001Dose of methacholine to maximal drop of forced expired volume in 1 second observable entity

1032001000000109Drug level observable entity

11881000237109Elastase mass content in faeces observable entity

2304051000000109Ethanol in urine qualitative result observable entity

2263191000000107Gabapentin in oral fluid qualitative result observable entity

2304091000000101Gabapentin in urine qualitative result observable entity

2981000237105HCG (human chorionic gonadotropin) multiple of the median in serum observable entity

5221000237108Inhibin-A multiple of the median in serum observable entity

439814009International normalised ratio derived warfarin dose observable entity

29981000237108Isocoproporphyrin molar content in faeces observable entity

1091871000000107Isotretinoin cumulative dose observable entity

2304061000000107Ketamine in urine qualitative result observable entity

409645006Lethal dose 50 observable entity

6631000237101Mandelic acid/creatinine molar concentration ratio in urine observable entity

2304281000000105Meconin in urine qualitative result observable entity

2263121000000109Metamfetamine in oral fluid qualitative result observable entity

2304131000000103Metamfetamine in urine qualitative result observable entity

2304221000000109Methadone metabolite in urine qualitative result observable entity

2283651000000109Methylenedioxymethamphetamine in oral fluid qualitative result observable entity

2304141000000107Methylenedioxymethamphetamine in urine qualitative result observable entity

4921000237100Monoclonal antibody protein/total protein mass concentration ratio in serum observable entity

9001000175100Name of medication injected observable entity

26221000237107Noradrenaline/creatinine molar concentration ratio in urine observable entity

2304311000000108O-acetylcodeine in urine qualitative result observable entity

16021000237107Oligoclonal bands number in CSF observable entity

2273281000000105Opioid in oral fluid qualitative result observable entity

2304321000000102Opioid in urine qualitative result observable entity

2304301000000106Papaverine in urine qualitative result observable entity

2051000237100Paraprotein percent in serum observable entity

999861000000109Plasma renin activity observable entity

25071000237107Plasma renin activity/aldosterone molar concentration ratio in urine observable entity

27651000237100Porphobilinogen/creatinine molar concentration ratio in urine observable entity

30811000237102Porphyrin molar content in faeces by high performance liquid chromatography observable entity

6641000237108Porphyrin/creatinine molar concentration ratio in urine observable entity

2263171000000108Pregabalin in oral fluid qualitative result observable entity

2304101000000109Pregabalin in urine qualitative result observable entity

2481000237103Pregnanediol/creatinine mass concentration ratio in urine observable entity

1181000237103Pregnanetriol/creatinine mass concentration ratio in urine observable entity

2941000237104Prolactin polyethylene glycol recovery percent in serum observable entity

54401000237109Recumbent renin enzyme activity in plasma observable entity

46691000237105Reticulin antibody titre in serum observable entity

443845002Rh>o<(D) immune globulin dose observable entity

53561000237109SAdo (succinyladenosine)/creatinine molar concentration ratio in urine observable entity

12061000237100Strontium/creatinine molar concentration ratio in urine observable entity

3331000237100THC (tetrahydrocortisone)/creatinine molar concentration ratio in urine observable entity

68181000237107Testostosterone/androstenedione mass ratio in plasma observable entity

6891000237104Tetrahydrocorticosterone/creatinine mass concentration ratio in urine observable entity

3941000237108Tetrahydrocortisol/creatinine mass concentration ratio in urine observable entity

5591000237108Tetrahydrocortisone/creatinine mass concentration ratio in urine observable entity

2891000237103Tetrahydrodeoxycortisol/creatinine mass concentration ratio in urine observable entity

427221004Therapeutic substance unit characteristic observable entity

6861000237108Unconjugated oestriol multiple of the median in serum observable entity

57281000237105Uracil/creatinine molar concentration ratio in urine observable entity

52101000237107Varicella zoster virus total antibody in CSF qualitative result observable entity

51101000237101Varicella zoster virus total antibody in serum qualitative result observable entity

422433003Volume of drug additive observable entity

849191000000105Warfarin daily dose observable entity

2304071000000100Zopiclone in urine qualitative result observable entity

13391000237102alpha-1 Antitrypsin mass content in faeces observable entity

57141000237107alpha-1-antitrypsin phenotype in blood observable entity

31371000237109alpha-1-antitrypsin phenotype in serum observable entity

58141000237108alpha-2-Antiplasmin percent activity in plasma observable entity

Parents (2)

Children (101)